Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q409935> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- Q409935 subject Q22230916.
- Q409935 subject Q6249541.
- Q409935 subject Q8492054.
- Q409935 abstract "Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). It was discovered by NeXstar Pharmaceuticals and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States. Outside the US pegaptanib is marketed by Pfizer. Approval was granted by the U.S. Food and Drug Administration (FDA) in December 2004.".
- Q409935 atcPrefix "S01".
- Q409935 atcSuffix "LA03".
- Q409935 casNumber "222716-86-1".
- Q409935 drugbank "DB04895".
- Q409935 fdaUniiCode "2H1PA8H1EN".
- Q409935 iupacName "RNA, ((2'-deoxy-2'-fluoro)C-Gm-Gm-A-A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-Am-Gm-(2'-deoxy-2'-fluoro)U-Gm-Am-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'fluoro)U-Am-(2'-deoxy-2'-fluoro)U-Am-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)U-(2'deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Gm-(3'→3')-dT), 5'-ester with α,α'-[4,12-dioxo-6[[[5-(phosphoonoxy)pentyl]amino]carbonyl]-3,13-dioxa-5,11-diaza-1,15-pentadecanediyl]bis[ω-methoxypoly(oxy-1,2-ethanediyl)], sodium salt".
- Q409935 thumbnail Pegaptanib_sodium_skeletal.svg?width=300.
- Q409935 wikiPageWikiLink Q123619.
- Q409935 wikiPageWikiLink Q1294912.
- Q409935 wikiPageWikiLink Q142807.
- Q409935 wikiPageWikiLink Q1428072.
- Q409935 wikiPageWikiLink Q156606.
- Q409935 wikiPageWikiLink Q161437.
- Q409935 wikiPageWikiLink Q166019.
- Q409935 wikiPageWikiLink Q180609.
- Q409935 wikiPageWikiLink Q2035485.
- Q409935 wikiPageWikiLink Q204711.
- Q409935 wikiPageWikiLink Q206921.
- Q409935 wikiPageWikiLink Q2102907.
- Q409935 wikiPageWikiLink Q22230916.
- Q409935 wikiPageWikiLink Q269829.
- Q409935 wikiPageWikiLink Q29725.
- Q409935 wikiPageWikiLink Q326710.
- Q409935 wikiPageWikiLink Q410943.
- Q409935 wikiPageWikiLink Q414270.
- Q409935 wikiPageWikiLink Q418722.
- Q409935 wikiPageWikiLink Q5105209.
- Q409935 wikiPageWikiLink Q539568.
- Q409935 wikiPageWikiLink Q5425270.
- Q409935 wikiPageWikiLink Q574834.
- Q409935 wikiPageWikiLink Q5911033.
- Q409935 wikiPageWikiLink Q608510.
- Q409935 wikiPageWikiLink Q609809.
- Q409935 wikiPageWikiLink Q6249541.
- Q409935 wikiPageWikiLink Q640448.
- Q409935 wikiPageWikiLink Q650050.
- Q409935 wikiPageWikiLink Q682252.
- Q409935 wikiPageWikiLink Q7073020.
- Q409935 wikiPageWikiLink Q7239206.
- Q409935 wikiPageWikiLink Q7260020.
- Q409935 wikiPageWikiLink Q830308.
- Q409935 wikiPageWikiLink Q8492054.
- Q409935 wikiPageWikiLink Q865103.
- Q409935 atcPrefix "S01".
- Q409935 atcSuffix "LA03".
- Q409935 casNumber "222716".
- Q409935 drugName "Pegaptanib sodium".
- Q409935 drugbank "DB04895".
- Q409935 iupacName "RNA, , 5'-ester with α,α'-[4,12-dioxo-6[[[5-pentyl]amino]carbonyl]-3,13-dioxa-5,11-diaza-1,15-pentadecanediyl]bis[ω-methoxypoly], sodium salt".
- Q409935 unii "2".
- Q409935 type ChemicalSubstance.
- Q409935 type Drug.
- Q409935 type ChemicalObject.
- Q409935 type Thing.
- Q409935 type Q8386.
- Q409935 comment "Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). It was discovered by NeXstar Pharmaceuticals and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States. Outside the US pegaptanib is marketed by Pfizer. Approval was granted by the U.S. Food and Drug Administration (FDA) in December 2004.".
- Q409935 label "Pegaptanib".
- Q409935 depiction Pegaptanib_sodium_skeletal.svg.
- Q409935 name "Pegaptanib sodium".